Related Experiment Video
Updated: Oct 11, 2025

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Prognosis and Long-Term Overall Survival in Hypertensive Patients Undergoing Chronic Hemodialysis: A Multicenter
Vahid Ebrahimi1, Mehrdad Sharifi2,3, Mohammad Hossein Khademian4
1Department of Biostatistics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Insights
Hypertension in hemodialysis patients has distinct short-term and long-term survival predictors. Factors like vascular access and membrane flux impact short-term outcomes, while age and dialysis adequacy are key for long-term survival.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Epidemiology
Background:
- Hypertensive hemodialysis (HTN-HD) patients face significant long-term complications.
- Management of hypertension in this population is often overlooked.
- This study identifies mortality determinants in HTN-HD patients.
Purpose of the Study:
- To identify factors influencing short-term and long-term overall survival (OS) in hypertensive hemodialysis patients.
- To differentiate between predictors of short-term versus long-term mortality.
Main Methods:
- Multicenter retrospective cohort study (2005-2018) involving 725 HTN-HD patients.
- Utilized accelerated failure time mixture split-population (AFTMSP) regression.
- Employed the extended generalized gamma (EGG) model for survival analysis.
Main Results:
- Short-term OS influenced by sex, initial vascular access (arteriovenous fistula), and high-flux membrane use.
- Long-term OS affected by age, dialysis adequacy (Kt/Vurea≤1.2), central venous catheter use, serum sodium, and potassium levels.
- The EGG model demonstrated superior performance in predicting survival.
Conclusions:
- Predictors for short-term and long-term survival in HTN-HD patients differ significantly.
- The parametric EGG model proved effective for survival analysis.
- Findings can inform health policy for improved long-term outcomes in HTN-HD patients.
Background:
Hemodialysis (HD) patients face long-term complications which require ongoing dialysis and follow-up. The management of hypertension among HD populations has often been neglected. This study aimed at identifying the determinants of death in hypertensive HD (HTN-HD) patients.
Methods:
In a multicenter retrospective cohort study (conducted from 2005 to 2018 in thirty-four HD centers affiliated with Shiraz University of Medical Sciences), the data of 725 HTN-HD patients who had at least 3 months of regular dialysis and follow-up were analyzed. Accelerated failure time mixture split-population (AFTMSP) regression was utilized to identify the factors with significant effects on long- and short-term overall survival (OS) separately.
Results:
Among the different AFTMSP models, the extended generalized gamma (EGG) model outperformed the others. Sex (male: event time ratio [ETR]=1.30), initial vascular access type (arteriovenous fistula: ETR=1.50), and the type of membrane flux used for HD (high-flux: ETR=1.27) had important impacts on short-term OS. Moreover, age (OR=1.06), dialysis adequacy (Kt/ Vurea≤1.2: OR=2.30), initial vascular access type (central venous catheter: OR=2.08), serum sodium (OR=0.90) concentration, and potassium (OR=0.66) concentration had significant effects on long-term OS.
Conclusion:
The split-population analyses were able to demonstrate that the predictors of long-term OS were different from those of short-term OS. Although the superiority of the parametric EGG model was proved in this study, further research with different databases is suggested. Moreover, these findings can be considered by health policy decision-makers to create a new guideline to enhance the long-term OS of HTN-HD patients.
Related Concept Videos
Hemodialysis III: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Hemodialysis II: Procedure and Complications
Comparing the Survival Analysis of Two or More Groups
Analysis of Population Pharmacokinetic Data
Hemodialysis I: Introduction

